Tinengotinib

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Tinengotinib 

Tinengotinib 是一种或多种蛋白激酶的调节剂，例如 Aurora 激酶和 VEGFR 激酶。Tinengotinib 具有研究这些激酶异常介导的疾病的潜力，尤其是癌症相关疾病 (摘自专利 WO2018108079A1)。

Tinengotinib

Tinengotinib Chemical Structure

CAS No. : 2230490-29-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Tinengotinib is the modulator of one or more protein kinases such as Aurora kinase and VEGFR kinase. Tinengotinib has the potential for the research of these kinase abnormalities diseases mediated, especially cancer-related diseases (extracted from patent WO2018108079A1)[1].

IC50 & Target

Aurora and VEGFR[1]
分子量

394.86

Formula

C20H19ClN6O
CAS 号

2230490-29-4
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Wu, Yongqian, et al. Multi-kinase inhibitor compound, and crystal form and use thereof. Patent WO2018108079A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务